Showing results (11-20 of 219) with videos related to
Sort By:
Pageof 22
Scientific Reports|June 17, 2015
CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcomaYan Gao, Yong Feng, Jacson K Shen, et al.Cancer|March 2, 2025
Adjuvant chemotherapy in localized, resectable extremity and truncal soft tissue sarcoma and survival outcomes - A systematic review and meta-analysis of randomized controlled trialsMegan H Goh, Marcos R Gonzalez, Hillary M Heiling, et al.European Journal of Cancer (Oxford, England : 1990)|January 4, 2020
A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomasGregory M Cote, Edwin Choy, Tianqi Chen, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2018
Clinicopathologic characteristics of poorly differentiated chordomaAngela R Shih, Gregory M Cote, Ivan Chebib, et al.Seminars in Oncology|February 25, 2014
Biosimilar safety considerations in clinical practiceEdwin Choy, Ira Allen JacobsPlos One|July 2, 2014
Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1Edwin Choy, Laura E MacConaill, Gregory M Cote, et al.Current Hematologic Malignancy Reports|April 20, 2011
Can low-risk, early-stage patients with Hodgkin lymphoma be spared radiotherapy?Gregory M Cote, George P CanellosThe Oncologist|May 7, 2022
Phase II Study of Cabozantinib in Patients With Bone MetastasisEdwin Choy, Gregory M Cote, M Dror Michaelson, et al.Sarcoma|January 10, 2020
Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single InstitutionRuoyu Miao, Edwin Choy, Kevin A Raskin, et al.The Oncologist|June 14, 2023
Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal TumorVinayak Venkataraman, Suzanne George, Gregory M CotePageof 22